Financials Skinvisible, Inc.

Equities

SKVI

US8307032032

Personal Products

Market Closed - OTC Markets 01:45:34 2024-04-22 pm EDT 5-day change 1st Jan Change
0.061 USD -39.60% Intraday chart for Skinvisible, Inc. -39.60% -27.21%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 2.028 0.2636 0.2951 1.09 0.459 0.3802
Enterprise Value (EV) 1 4.841 2.353 3.02 4.107 4.094 6.532
P/E ratio 12.7 x -0.16 x -0.2 x -1 x -0.37 x -0.16 x
Yield - - - - - -
Capitalization / Revenue 29.2 x 6.11 x 1.07 x 1.64 x 1.64 x 19 x
EV / Revenue 69.8 x 54.5 x 11 x 6.19 x 14.7 x 327 x
EV / EBITDA -8.66 x -4.7 x -13.6 x 19.9 x -18.6 x -13.9 x
EV / FCF -11.1 x -1.69 x 5.28 x 6.09 x 10.5 x -19.1 x
FCF Yield -9.02% -59.2% 18.9% 16.4% 9.57% -5.24%
Price to Book -0.43 x -0.14 x -0.07 x -0.2 x -0.07 x -0.04 x
Nbr of stocks (in thousands) 2,897 2,897 4,540 4,540 4,540 4,540
Reference price 2 0.7000 0.0910 0.0650 0.2401 0.1011 0.0838
Announcement Date 4/15/19 5/14/20 4/15/21 3/31/22 3/30/23 4/16/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 0.0693 0.0432 0.2756 0.6634 0.2793 0.02
EBITDA 1 -0.559 -0.5002 -0.2216 0.206 -0.2197 -0.4716
EBIT 1 -0.5979 -0.5398 -0.2537 0.1881 -0.2384 -0.4904
Operating Margin -862.24% -1,250.47% -92.06% 28.35% -85.37% -2,451.88%
Earnings before Tax (EBT) 1 0.1583 -1.702 -1.448 -1.073 -1.225 -2.382
Net income 1 0.1583 -1.702 -1.448 -1.073 -1.225 -2.382
Net margin 228.33% -3,943.22% -525.34% -161.7% -438.56% -11,912.2%
EPS 2 0.0551 -0.5700 -0.3222 -0.2400 -0.2700 -0.5248
Free Cash Flow 1 -0.4365 -1.393 0.5719 0.6741 0.3917 -0.3422
FCF margin -629.4% -3,226.14% 207.53% 101.61% 140.25% -1,710.98%
FCF Conversion (EBITDA) - - - 327.19% - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 4/15/19 5/14/20 4/15/21 3/31/22 3/30/23 4/16/24
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 2.81 2.09 2.72 3.02 3.63 6.15
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) -5.033 x -4.178 x -12.29 x 14.64 x -16.54 x -13.05 x
Free Cash Flow 1 -0.44 -1.39 0.57 0.67 0.39 -0.34
ROE (net income / shareholders' equity) -2.76% 44.1% 38.8% 21.7% 20.3% 30.4%
ROA (Net income/ Total Assets) -87.7% -168% -83% 55% -62.9% -150%
Assets 1 -0.1806 1.015 1.744 -1.951 1.948 1.592
Book Value Per Share 2 -1.630 -0.6700 -0.9800 -1.190 -1.460 -1.990
Cash Flow per Share 2 0 0 0.0100 0.0100 0.0200 0
Capex 1 0.01 - - - - -
Capex / Sales 16.6% - - - - -
Announcement Date 4/15/19 5/14/20 4/15/21 3/31/22 3/30/23 4/16/24
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. SKVI Stock
  4. Financials Skinvisible, Inc.